Cargando…
Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series
The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India’s traditional system of Ayurveda for its immune booster properties and has been extensively used as prophylaxis against...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252698/ https://www.ncbi.nlm.nih.gov/pubmed/34230786 http://dx.doi.org/10.1016/j.jceh.2021.06.021 |
_version_ | 1783717353822879744 |
---|---|
author | Nagral, Aabha Adhyaru, Kunal Rudra, Omkar S. Gharat, Amit Bhandare, Sonal |
author_facet | Nagral, Aabha Adhyaru, Kunal Rudra, Omkar S. Gharat, Amit Bhandare, Sonal |
author_sort | Nagral, Aabha |
collection | PubMed |
description | The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India’s traditional system of Ayurveda for its immune booster properties and has been extensively used as prophylaxis against COVID-19. Six patients (4 women, 2 men) with a median (IQR) age of 55 years (45–56) and with an history of Tinospora cordifolia consumption presented with symptoms of acute hepatitis during the study period of 4 months in the COVID-19 pandemic. The median (IQR) duration of Tinospora cordifolia consumption was 90 days (21–210). The median (IQR) peak bilirubin and AST were 17.5 mg/dl (12.2–24.9) and 1350 IU/ml (1099-1773), respectively. The patients had either a definite (n = 4) or probable (n = 2) revised autoimmune hepatitis score with an autoimmune pattern of drug-induced liver injury on biopsy. Four of these patients (all women) had underlying silent chronic liver disease of possible autoimmune etiology associated with other autoimmune diseases – hypothyroidism and type 2 diabetes mellitus. One of the three patients treated with steroids decompensated on steroid tapering. The other five patients had resolution of symptoms, liver profile, and autoimmune serological markers on drug withdrawal/continuing steroid treatment. The median (IQR) time to resolution from discontinuing the herb was 86.5 days (53-111). Tinospora cordifolia consumption seems to induce an autoimmune-like hepatitis or unmask an underlying autoimmune chronic liver disease, which may support its immune stimulant mechanism. However, the same mechanism can cause significant liver toxicity, and we recommend that caution be exercised in the use of this herb, especially in those predisposed to autoimmune disorders. Besides, in patients presenting with acute hepatitis, even in the presence of autoimmune markers, a detailed complementary and alternative medicine history needs to be elicited. |
format | Online Article Text |
id | pubmed-8252698 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82526982021-07-02 Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series Nagral, Aabha Adhyaru, Kunal Rudra, Omkar S. Gharat, Amit Bhandare, Sonal J Clin Exp Hepatol Case Report The COVID-19 pandemic has resulted in widespread use of complementary and alternative medicines. Tinospora cordifolia is a widely grown shrub which has been commonly used in India’s traditional system of Ayurveda for its immune booster properties and has been extensively used as prophylaxis against COVID-19. Six patients (4 women, 2 men) with a median (IQR) age of 55 years (45–56) and with an history of Tinospora cordifolia consumption presented with symptoms of acute hepatitis during the study period of 4 months in the COVID-19 pandemic. The median (IQR) duration of Tinospora cordifolia consumption was 90 days (21–210). The median (IQR) peak bilirubin and AST were 17.5 mg/dl (12.2–24.9) and 1350 IU/ml (1099-1773), respectively. The patients had either a definite (n = 4) or probable (n = 2) revised autoimmune hepatitis score with an autoimmune pattern of drug-induced liver injury on biopsy. Four of these patients (all women) had underlying silent chronic liver disease of possible autoimmune etiology associated with other autoimmune diseases – hypothyroidism and type 2 diabetes mellitus. One of the three patients treated with steroids decompensated on steroid tapering. The other five patients had resolution of symptoms, liver profile, and autoimmune serological markers on drug withdrawal/continuing steroid treatment. The median (IQR) time to resolution from discontinuing the herb was 86.5 days (53-111). Tinospora cordifolia consumption seems to induce an autoimmune-like hepatitis or unmask an underlying autoimmune chronic liver disease, which may support its immune stimulant mechanism. However, the same mechanism can cause significant liver toxicity, and we recommend that caution be exercised in the use of this herb, especially in those predisposed to autoimmune disorders. Besides, in patients presenting with acute hepatitis, even in the presence of autoimmune markers, a detailed complementary and alternative medicine history needs to be elicited. Elsevier 2021 2021-07-02 /pmc/articles/PMC8252698/ /pubmed/34230786 http://dx.doi.org/10.1016/j.jceh.2021.06.021 Text en © 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved. |
spellingShingle | Case Report Nagral, Aabha Adhyaru, Kunal Rudra, Omkar S. Gharat, Amit Bhandare, Sonal Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series |
title | Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series |
title_full | Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series |
title_fullStr | Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series |
title_full_unstemmed | Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series |
title_short | Herbal Immune Booster-Induced Liver Injury in the COVID-19 Pandemic - A Case Series |
title_sort | herbal immune booster-induced liver injury in the covid-19 pandemic - a case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252698/ https://www.ncbi.nlm.nih.gov/pubmed/34230786 http://dx.doi.org/10.1016/j.jceh.2021.06.021 |
work_keys_str_mv | AT nagralaabha herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries AT adhyarukunal herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries AT rudraomkars herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries AT gharatamit herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries AT bhandaresonal herbalimmuneboosterinducedliverinjuryinthecovid19pandemicacaseseries |